Kenvue (KVUE)
International Stocks
Buy
Discusses the attractive entry level and activist involvement, suggesting the Tylenol litigation risks may fade.
Guy Adami
CNBC Television
Loading...
Coverage, strength, recency, conviction and momentum.
No analyses found yet.
Newest calls at the top.
Discusses the attractive entry level and activist involvement, suggesting the Tylenol litigation risks may fade.
Discusses the attractive entry level and activist involvement, suggesting the Tylenol litigation risks may fade.